Bovie Medical provides update on J-Plasma Bovie Medical provided an update on operating developments. The company announced that the first two white papers on J-Plasma will be published on July 1 and made available simultaneously on Bovie Medical’s website. The first paper tracks J-Plasma’s effect on tissue compared to the effects of cautery, argon and monopolar lasers, and the other analyzes the versatility of the J-Plasma product’s power settings. A third white paper that evaluates the pre- and post-procedural results on facial wrinkles is scheduled to be published in the third quarter. “We continue to progress on or ahead of schedule with the commercialization of our J-Plasma product,” said Robert L. Gershon, CEO.